AI tool for thymus tumors
Part of Blood & lymphatic, Cancer clinical trials.
This study is using an artificial intelligence tool to help doctors better predict how thymus tumors (thymoma and thymic carcinoma) will behave. It may help guide decisions about treatment and follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of one of these thymus tumor types: Thymoma A, AB, B1, B2, B3, or Thymic Carcinoma.
- The diagnosis must have been made with less than 70% agreement among pathologists (meaning there was some uncertainty).
- For part of the study, you must have information about whether the tumor came back (recurred) within 5 years after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an artificial intelligence (AI) helper that assists doctors in managing thyroid cancer. It aims to see if the tool can improve care for patients like you.
This trial uses an artificial intelligence system to help doctors more accurately diagnose and predict the outcome of breast phyllodes tumors, which are rare breast growths. It aims to improve how these tumors are identified and managed.
This trial is testing an artificial intelligence system that helps doctors diagnose ovarian tumors more accurately using imaging and blood tests. It may lead to better treatment decisions for patients.
This study uses artificial intelligence to look at ultrasound images and lymph node samples from people with thyroid cancer. The goal is to see if the AI can help predict whether cancer has spread to lymph nodes, which may guide treatment decisions.
This study uses artificial intelligence to help doctors predict the best treatment for prostate cancer. It may help match you with the most effective care based on your specific situation.
This study uses artificial intelligence to analyze electronic health records (including medical history, lab results, and imaging data) to improve cancer diagnosis and prediction. It aims to help identify cancer earlier and more accurately, potentially leading to better treatment outcomes.
Hear when a new Thymic Epithelial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.